Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2025-12-28 @ 11:29 AM
Study NCT ID:
NCT02328950
Status:
UNKNOWN
Last Update Posted:
2016-02-17
First Post:
2014-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Sponsor:
Fujian Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FA5Bucy-SCT-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None